Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inspire Veterinary Partners (IVPR) EBITDA (2022 - 2025)

Historic EBITDA for Inspire Veterinary Partners (IVPR) over the last 4 years, with Q3 2025 value amounting to -$1.8 million.

  • Inspire Veterinary Partners' EBITDA rose 1452.42% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year increase of 1877.32%. This contributed to the annual value of -$8.5 million for FY2024, which is 2692.41% down from last year.
  • Inspire Veterinary Partners' EBITDA amounted to -$1.8 million in Q3 2025, which was up 1452.42% from -$2.5 million recorded in Q2 2025.
  • Inspire Veterinary Partners' EBITDA's 5-year high stood at -$811635.0 during Q2 2023, with a 5-year trough of -$2.7 million in Q1 2024.
  • For the 4-year period, Inspire Veterinary Partners' EBITDA averaged around -$1.8 million, with its median value being -$1.9 million (2025).
  • Over the last 5 years, Inspire Veterinary Partners' EBITDA had its largest YoY gain of 3832.51% in 2024, and its largest YoY loss of 20715.39% in 2024.
  • Over the past 4 years, Inspire Veterinary Partners' EBITDA (Quarter) stood at -$1.2 million in 2022, then tumbled by 85.66% to -$2.3 million in 2023, then skyrocketed by 38.33% to -$1.4 million in 2024, then decreased by 27.69% to -$1.8 million in 2025.
  • Its EBITDA stands at -$1.8 million for Q3 2025, versus -$2.5 million for Q2 2025 and -$1.9 million for Q1 2025.